Renaissance Technologies’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-2,006
Closed -$21.4K – 3267
2025
Q4
$21.4K Buy
+2,006
New +$52.7K ﹤0.01% 3145
2024
Q4
– Sell
-171
Closed -$17.4K – 3578
2024
Q3
$17.4K Buy
+171
New +$49K ﹤0.01% 3436
2024
Q2
– Sell
-3
Closed -$14K – 3509
2024
Q1
$14K Buy
+3
New +$16.5K ﹤0.01% 3614
2023
Q3
– Hold
0
– -$13K – 3677
2023
Q2
– Hold
0
– – – 3813
2023
Q1
– Sell
-1
Closed -$70.9K – 3855
2022
Q4
$25K Buy
+1
New +$86.6K ﹤0.01% 3919
2022
Q3
– Hold
0
– – – 3811
2022
Q2
– Hold
0
– – – 3986

Other funds holding BJDX

Renaissance Technologies's BJDX Position: Q1 2026 in Review

Renaissance Technologies sold out of Bluejay Diagnostics (BJDX) in Q1 2026, closing a stake of 2,006 shares — an estimated $21.4K sold.

Renaissance Technologies first reported a position in BJDX in Q4 2022 and held it in 4 quarters. The position peaked at $25K in Q4 2022. 6 funds tracked by Wall St. Rank hold BJDX as of Q1 2026.

  • Renaissance Technologies reported no remaining Bluejay Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 2,006 Bluejay Diagnostics shares in Q1 2026, an estimated $21.4K.
  • Renaissance Technologies first reported a position in Bluejay Diagnostics in Q4 2022 and held it in 4 quarters.
  • Renaissance Technologies's Bluejay Diagnostics position peaked at $25K in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.